Abstract: We consider estimating the effect that discontinuing a beneficial treatment will have on the distribution of a time to event clinical outcome. In particular, we are interested in assessing whether there is a period of time over which the beneficial effect may continue after discontinuation and if so how long does such a "legacy" effect last. There are two major challenges. The first is to make a distinction between mandatory discontinuation, where by necessity treatment has to be terminated and optional discontinuation which is decided by the preference of the patient or physician. If we view treatment discontinuation as an intervention, then it only makes sense to consider optional treatment discontinuation where either choice of continuing treatment or not could have been made.
